What is SNAP-8 | 10MG

SNAP-8 | 10MG is a synthetic octapeptide studied extensively in cosmetic and dermatological research as a safer, topical alternative to Botulinum Toxin (Botox) for wrinkle reduction. It is intended exclusively for research use.

Regarding its chemical identity, SNAP-8 has a molecular formula of C41H70N16O16S and a molecular weight of 1075.2 g/mol. Its reported canonical sequence is Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2. A confirmed CAS number is not available in open primary reference sources and is therefore omitted.

Its synonyms include SNAP-8.

Product for research use.

Mechanism of action of SNAP-8

SNAP-8 acts by competing with the natural protein SNAP-25 for a position in the SNARE complex. By destabilizing this complex, it significantly inhibits the release of acetylcholine at the neuromuscular junction. This mildly paralyzes or relaxes the facial muscles, reducing dynamic wrinkles.

Pharmacokinetics and pharmacodynamics of SNAP-8

Designed for topical application, it is highly lipophilic to penetrate the stratum corneum. It remains localized in the upper dermal layers and superficial muscle fibers, exhibiting no systemic absorption or widespread paralytic effects.

Scientific evidence on SNAP-8

The available evidence on SNAP-8 is preliminary and largely inconclusive, and should be interpreted with caution. The literature describes it as having been investigated for multiple indications in preclinical models.

Investigated in clinical dermatology as a topical anti-aging treatment. Studies demonstrate a significant reduction in the depth of facial wrinkles (particularly around the eyes and forehead) by up to 34% over a month of continuous application.

SNAP-8 applications in research

Ideal for (research context):
– In vitro and preclinical studies of its specific receptor pathways.
– Investigation of tissue repair, cell proliferation, and functional restoration in laboratory models.
– Comparative work with related peptides.

Not applicable for:
– clinical, diagnostic or therapeutic use.
– Any administration to humans or animals outside of an authorized research protocol.

Product for research use.

SNAP-8 protocols in preclinical studies

The literature consulted does not include numerical doses from studies that can be cited for SNAP-8, so no trial schemes or quantities are specified.

The presentations of this product (10MG) refer only to the amount of lyophilized peptide per vial (or volume for liquids) and do not constitute a dosage recommendation. The design of any protocol, including concentrations and working volumes, is the responsibility of the researcher, based on their experimental objectives and the relevant primary literature.

Information provided exclusively for research purposes.

Reconstitution and manipulation of SNAP-8

As a general guideline for laboratory handling, lyophilized peptides such as SNAP-8 are usually reconstituted with bacteriostatic water (sterile water with approximately 0.9% benzyl alcohol).

Add the solvent slowly down the side of the vial, letting it run over the lyophilized powder; avoid injecting the stream directly onto the powder.
Do not shake: gently rotate the vial until completely dissolved.
Adjust the solvent volume according to the desired working concentration, considering the 10MG contents of the vial.

These guidelines are for general technique and do not replace the internal procedures of each laboratory.

SNAP-8 Stability and Storage

As a standard laboratory handling procedure for peptides:

Freeze-dried (unreconstituted): This is the most stable form. It is best preserved by freezing and protecting it from moisture and light for long-term storage.
Reconstituted: once in solution, the peptide is less stable and must be kept refrigerated, being used within a short period; for extended storage, freezing in aliquots is usually preferred.
Avoid repeated freeze-thaw cycles, as they can degrade the peptide.

Given that the molecule is characterized by rapid enzymatic degradation in biological media, careful cold chain management is especially relevant.

Documented SNAP-8 security profile

The documented safety information in open sources for SNAP-8 is limited and should be interpreted with caution, also considering that it is research material and not for clinical use.

Considered extremely safe for topical use. Because its mechanism of action is competitive inhibition rather than the irreversible destruction of the SNARE complex (like Botox), its effects are mild, temporary, and carry no risk of systemic toxicity.

Formal contraindications and adverse event rates are not available in the consulted literature, so no figures are reported.

SNAP-8 in a comparative context

SNAP-8 is an elongation of the famous hexapeptide Argireline (SNAP-25). The addition of two amino acids makes SNAP-8 approximately 30% more potent at inhibiting neurotransmitter release than Argireline. Compared to Botox, it is applied topically and is entirely non-toxic.

History and development of SNAP-8

Developed by Lipotec in Spain as part of a continuing effort to improve the efficacy of topical “Botox-like” peptides. It represents an evolutionary step forward from Argireline in the highly lucrative cosmetic peptide market.